article thumbnail

Q&A with Rami Rajab and Inna Nadelwais, Mecomed

Healthcare Innovation Consortium

We aim to bring together relevant stakeholders, including payers, providers, patients groups, and biotech and when and where needed we cooperate with pharma, to be the one voice of the industry. Inna: Our aim is to improve patient and clinician access to modern, innovative and reliable medical technology.

BioTech 60
article thumbnail

Vektor Medical Secures $16 Million Series A Funding

Digital Health Global

To bolster this expansion, Vektor will increase clinical support and drive additional clinical studies to showcase the technology’s impact and inform future innovation as well as continue efforts to secure reimbursement. “At TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics.